Annual report pursuant to Section 13 and 15(d)

Statements of Changes in Stockholders' Equity

v3.24.0.1
Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2021 $ 2 $ 111,588 $ (89,368) $ 22,222
Balance (in shares) at Dec. 31, 2021 18,845,828      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock in connection with the at-the-market program and purchase agreement $ 0 4,428 0 4,428
Issuance of common stock in connection with the at-the-market program and purchase agreement (in shares) 1,848,980      
Issuance costs $ 0 (133) 0 (133)
Exercise of Series B warrants $ 0 0 0 0
Exercise of Series B warrants (in shares) 60,832      
Stock-based compensation $ 0 1,807 0 1,807
Stock-based compensation (in shares) 81,366      
Exercise of stock options $ 0 27 0 27
Exercise of stock options (in shares) 24,309      
Net and comprehensive income (loss) $ 0 0 17,888 17,888
Balance at Dec. 31, 2022 $ 2 117,717 (71,480) 46,239
Balance (in shares) at Dec. 31, 2022 20,861,315      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock in connection with the at-the-market program and purchase agreement $ 0 10,249 0 10,249
Issuance of common stock in connection with the at-the-market program and purchase agreement (in shares) 2,964,238      
Issuance costs $ 0 (136) 0 (136)
Exercise of Series B warrants $ 0 0 0 0
Exercise of Series B warrants (in shares) 17,869      
Stock-based compensation $ 0 3,510 0 3,510
Stock-based compensation (in shares) 106,600      
Exercise of stock options $ 0 30 0 30
Exercise of stock options (in shares) 27,469      
Net and comprehensive income (loss) $ 0 0 (9,986) (9,986)
Balance at Dec. 31, 2023 $ 2 $ 131,370 $ (81,466) $ 49,906
Balance (in shares) at Dec. 31, 2023 23,977,491